1 1639 105 MODULATION OF IMMUNE RESPONSES IN STRESS BY YOGA. STRESS IS A CONSTANT FACTOR IN TODAY'S FASTPACED LIFE THAT CAN JEOPARDIZE OUR HEALTH IF LEFT UNCHECKED. IT IS ONLY IN THE LAST HALF CENTURY THAT THE ROLE OF STRESS IN EVERY AILMENT FROM THE COMMON COLD TO AIDS HAS BEEN EMPHASIZED, AND THE MECHANISMS INVOLVED IN THIS PROCESS HAVE BEEN STUDIED. STRESS INFLUENCES THE IMMUNE RESPONSE PRESUMABLY THROUGH THE ACTIVATION OF THE HYPOTHALAMIC-PITUITARY ADRENAL AXIS, HYPOTHALAMIC PITUITARY-GONADAL AXIS, AND THE SYMPATHETIC-ADRENAL-MEDULLARY SYSTEM. VARIOUS NEUROTRANSMITTERS, NEUROPEPTIDES, HORMONES, AND CYTOKINES MEDIATE THESE COMPLEX BIDIRECTIONAL INTERACTIONS BETWEEN THE CENTRAL NERVOUS SYSTEM (CNS) AND THE IMMUNE SYSTEM. THE EFFECTS OF STRESS ON THE IMMUNE RESPONSES RESULT IN ALTERATIONS IN THE NUMBER OF IMMUNE CELLS AND CYTOKINE DYSREGULATION. VARIOUS STRESS MANAGEMENT STRATEGIES SUCH AS MEDITATION, YOGA, HYPNOSIS, AND MUSCLE RELAXATION HAVE BEEN SHOWN TO REDUCE THE PSYCHOLOGICAL AND PHYSIOLOGICAL EFFECTS OF STRESS IN CANCERS AND HIV INFECTION. THIS REVIEW AIMS TO DISCUSS THE EFFECT OF STRESS ON THE IMMUNE SYSTEM AND EXAMINE HOW RELAXATION TECHNIQUES SUCH AS YOGA AND MEDITATION COULD REGULATE THE CYTOKINE LEVELS AND HENCE, THE IMMUNE RESPONSES DURING STRESS. 2008 2 2886 32 YOGA: BALANCING THE EXCITATION-INHIBITION EQUILIBRIUM IN PSYCHIATRIC DISORDERS. SOCIAL BEHAVIORAL DISTURBANCES ARE CENTRAL TO MOST PSYCHIATRIC DISORDERS. A DISEQUILIBRIUM WITHIN THE CORTICAL EXCITATORY AND INHIBITORY NEUROTRANSMITTER SYSTEMS UNDERLIES THESE DEFICITS. GAMMA-AMINOBUTYRIC ACID (GABA) AND GLUTAMATE ARE THE MOST ABUNDANT EXCITATORY AND INHIBITORY NEUROTRANSMITTERS IN THE BRAIN THAT CONTRIBUTE TO THIS EQUILIBRIUM. SEVERAL CONTEMPORARY THERAPIES USED IN TREATING PSYCHIATRIC DISORDERS, REGULATE THIS GABA-GLUTAMATE BALANCE. YOGA HAS BEEN STUDIED AS AN ADJUVANT TREATMENT ACROSS A BROAD RANGE OF PSYCHIATRIC DISORDERS AND IS SHOWN TO HAVE SHORT-TERM THERAPEUTIC GAINS. EMERGING EVIDENCE FROM RECENT CLINICAL IN VIVO EXPERIMENTS SUGGESTS THAT YOGA IMPROVES GABA-MEDIATED CORTICAL-INHIBITORY TONE AND ENHANCES PERIPHERAL OXYTOCIN LEVELS. THIS IS LIKELY TO HAVE A MORE CONTROLLED DOWNSTREAM RESPONSE OF THE HYPOTHALAMO-PITUITARY-ADRENAL SYSTEM BY MEANS OF REDUCED CORTISOL RELEASE AND HENCE A BLUNTED SYMPATHETIC RESPONSE TO STRESS. ANIMAL AND EARLY FETAL DEVELOPMENTAL STUDIES SUGGEST AN INTER-DEPENDENT ROLE OF OXYTOCIN AND GABA IN REGULATING SOCIAL BEHAVIORS. IN KEEPING WITH THESE OBSERVATIONS, WE PROPOSE AN INTEGRATED NEUROBIOLOGICAL MODEL TO STUDY THE MECHANISMS OF THERAPEUTIC BENEFITS WITH YOGA. APART FROM PROVIDING A NEUROSCIENTIFIC BASIS FOR APPLYING A TRADITIONAL SYSTEM OF PRACTICE IN THE CLINICAL SETTING, THIS MODEL CAN BE USED AS A FRAMEWORK FOR STUDYING YOGA MECHANISMS IN FUTURE CLINICAL TRIALS. 2019 3 2608 16 YOGA FOR PSYCHIATRIC DISORDERS: FROM FAD TO EVIDENCE-BASED INTERVENTION? THERE IS GROWING EVIDENCE FOR YOGA'S NEUROBIOLOGICAL EFFECTS IN PEOPLE WITH PSYCHIATRIC DISORDERS. POSTULATED MECHANISMS OF ACTION INCLUDE: (A) MODULATION OF THE HYPOTHALAMIC-PITUITARY-ADRENAL (HPA) AXIS; (B) ENHANCEMENT OF GABAERGIC NEUROTRANSMISSION; (C) AUTONOMIC MODULATION; AND (D) NEUROENDOCRINOLOGICAL EFFECTS. YOGA AS A THERAPEUTIC INTERVENTION IN PSYCHIATRIC DISORDERS APPEARS PROMISING AND MERITS FURTHER ATTENTION IN CLINICAL PRACTICE AND RESEARCH. 2020 4 1634 30 MODELING THE EFFECTS OF YOGA ON THE PROGRESSION OF ALZHEIMER'S DISEASE IN A DISH. ALZHEIMER'S DISEASE (AD) ACCOUNTS FOR 80% OF ALL DEMENTIA CASES, MAKING IT THE MOST COMMON FORM OF DEMENTIA. AGING SERVES AS THE MAIN RISK FACTOR FOR AD, BUT EARLY ONSET AD CAN ALSO OCCUR IN INDIVIDUALS YOUNGER THAN 65 YEARS. AD RESULTS FROM PROGRESSIVE NEURODEGENERATION LEADING TO DYSFUNCTIONAL SYNAPTIC TRANSMISSION IN THE BRAIN. THE CASCADE HYPOTHESIS OF AD STATES THAT AMYLOID PRECURSOR PROTEIN (APP) METABOLISM BECOMES IMPAIRED EITHER BY MUTATION OR AN INTERLEUKIN-MEDIATED STRESS RESPONSE TO INJURY, RESULTING IN THE SPLICING OF HARMFUL OLIGOMERIC FORMS OF AMYLOID BETA (ABETA). THESE OLIGOMERS DISRUPT EXTRACELLULAR RECEPTOR BINDING, INTRACELLULAR FUNCTION, AND CELLULAR MEMBRANE INTEGRITY. YOGA AND MEDITATIVE PRACTICES SLOW THE PROGRESSION OF THE COGNITIVE DECLINE ASSOCIATED WITH AD. HOWEVER, THE BIOLOGICAL MECHANISMS UNDERLYING THIS THERAPEUTIC EFFECT REMAIN ELUSIVE. HERE, WE INVESTIGATED THE ABILITY OF NEUROTRANSMITTERS RELEASED DURING YOGA AND MEDITATIVE PRACTICES TO RESCUE NEURONS FROM SYNAPTIC DYSFUNCTION IN AN IN VITRO ALZHEIMER'S MODEL CREATED BY CULTURING BASAL FOREBRAIN CHOLINERGIC NEURONS WITH PHYSIOLOGICALLY RELEVANT LEVELS OF THE I-42 ISOFORM OF OLIGOMERIC ABETA (OALPHABETAI-42). WE FOUND THAT THE NEUROTRANSMITTERS DOPAMINE AND HISTAMINE PRODUCE A COOPERATIVE ACTION WITH SEROTONIN TO REVERSE THE LOSS OF CHOLINE ACETYLTRANSFERASE (CHAT) BY OALPHABETAI-42. THE LOSS OF CHAT, THE ENZYME RESPONSIBLE FOR PROCESSING THE CHOLINERGIC NEUROTRANSMITTER ACETYLCHOLINE, CONTRIBUTES TO THE SYNAPTIC DYSFUNCTION EXPERIENCED DURING AD. THESE NEUROTRANSMITTERS INHIBIT NITRIC OXIDE SYNTHESIS CAUSED BY OALPHABETAI-42, PREVENTING OXIDATIVE AND NITROSATIVE STRESS. SEROTONIN ACTIVATES AN ALTERNATE CLEAVAGE OF APP TO PRODUCE A FRAGMENT WITH KNOWN NEUROTROPHIC EFFECTS, GIVING IT THE UNIQUE ABILITY TO INHIBIT THE OALPHABETAI-42 PRODUCTION CYCLE. WE HYPOTHESIZE HERE THAT THESE CONCERTED ACTIONS LEAD TO THE PROTECTION OF CHOLINERGIC SYNAPTIC TRANSMISSION IN AD. 2018 5 2297 20 THERAPEUTIC ROLE OF YOGA IN NEUROPSYCHOLOGICAL DISORDERS. YOGA IS CONSIDERED A WIDELY-USED APPROACH FOR HEALTH CONSERVATION AND CAN BE ADOPTED AS A TREATMENT MODALITY FOR A PLETHORA OF MEDICAL CONDITIONS, INCLUDING NEUROLOGICAL AND PSYCHOLOGICAL DISORDERS. HENCE, WE REVIEWED RELEVANT ARTICLES ENTAILING VARIOUS NEUROLOGICAL AND PSYCHOLOGICAL DISORDERS AND GATHERED DATA ON HOW YOGA EXERTS POSITIVE IMPACTS ON PATIENTS WITH A DIVERSE RANGE OF DISORDERS, INCLUDING ITS MODULATORY EFFECTS ON BRAIN BIOELECTRICAL ACTIVITIES, NEUROTRANSMITTERS, AND SYNAPTIC PLASTICITY. THE ROLE OF YOGA PRACTICE AS AN ELEMENT OF THE TREATMENT OF SEVERAL NEUROPSYCHOLOGICAL DISEASES WAS EVALUATED BASED ON THESE FINDINGS. 2021 6 1590 22 MEDITATION AND YOGA CAN MODULATE BRAIN MECHANISMS THAT AFFECT BEHAVIOR AND ANXIETY-A MODERN SCIENTIFIC PERSPECTIVE. MEDITATION AND YOGA TECHNIQUES ARE RECEIVING INCREASED ATTENTION THROUGHOUT THE WORLD, DUE TO THE ACCUMULATION OF EVIDENCE BASED RESEARCH THAT PROVES THE DIRECT AND INDIRECT BENEFITS OF SUCH PRACTICES. BASED ON STUDIES CONDUCTED SO FAR, IT HAS BEEN FOUND THAT THE PRACTICE OF MEDITATION TRIGGERS NEUROTRANSMITTERS THAT MODULATE PSYCHOLOGICAL DISORDERS SUCH AS ANXIETY. THIS PAPER WILL REVIEW THE PSYCHOLOGICAL EFFECTS OF THE PRACTICE OF MEDITATION, THE ROLE OF NEUROTRANSMITTERS, AND STUDIES USING EEG AND FMRI. 2015 7 82 36 A MECHANISTIC MODEL FOR YOGA AS A PREVENTIVE AND THERAPEUTIC MODALITY. YOGA IS AN ANCIENT INDIAN TECHNIQUE OF HEALTHY LIVING. NUMEROUS STUDIES HAVE CORROBORATED YOGA'S BENEFICIAL EFFECTS, INCLUDING A FAVORABLE INFLUENCE ON AUTONOMIC FUNCTION AND NEGATIVE EMOTIONS. EXTENSIVE RESEARCH IN THE LAST FEW DECADES HAS REVEALED THE CRITICAL ROLE THAT YOGA CAN PLAY IN ERADICATING STRESS. THIS HAS LAID TO THE FOUNDATION FOR A SCIENTIFIC UNDERSTANDING OF PATHOPHYSIOLOGICAL CHANGES ATTRIBUTED TO STRESS, PARTICULARLY AT THE MOLECULAR AND GENETIC LEVELS. THIS PRIMARILY HAS HELPED UNDERSTAND THE EPIGENETIC AND GENETIC MECHANISM AT PLAY TO INDUCE AND ALLEVIATE STRESS, PARTICULARLY THOSE RELATED TO EMOTIONAL ABERRATIONS. AS RESEARCH HAS INDICATED, NEGATIVE EMOTIONS ARE TRANSLATED INTO VASCULAR INFLAMMATION APPROPRIATELY ACCENTUATED BY A SYMPATHETIC PREDOMINANT AUTONOMIC FUNCTION. THIS CASCADE IS BOLSTERED BY MULTIPLE FACTORS, INCLUDING ACTIVATION OF "STRESSOR" GENES AND ELABORATING HORMONES, INCLUDING STEROIDS WITH SOMETIMES NOCUOUS CONSEQUENCES, PARTICULARLY WHEN CHRONIC. YOGA HAS BEEN CATEGORICALLY FOUND TO HAVE INHIBITED EACH AND EVERY ONE OF THESE BANEFUL EFFECTS OF STRESS. IN FACT, IT ALSO CHANGES THE NEURONAL CIRCUITS THAT POTENTIATE SUCH A PLETHORA OF PATHOLOGICAL CHANGES. THIS, IN TURN, HAS ACCENTUATED YOGA'S RELEVANCE AS A POWERFUL PREVENTIVE INTERVENTION IN NONCOMMUNICABLE DISEASES (NCD). NCDS, INCLUDING HEART DISEASE, STROKE, AND RHEUMATOLOGICAL DISORDERS, ARE ESSENTIALLY INFLAMMATORY DISEASES THAT PERPETUATE INFLAMMATION IN DIFFERENT BEDS LIKE VASCULAR OR JOINT SPACES. THE PRECISE MECHANISM BY WHICH YOGA INDUCES SUCH BENEFICIAL CHANGES IS YET TO BE DELINEATED. HOWEVER, A CORNUCOPIA OF POINTERS INDICATES THAT NEURAL, ENDOCRINE, IMMUNOLOGICAL, CELLULAR, GENETIC, AND EPIGENETIC MECHANISMS ARE AT PLAY. THIS ARTICLE ATTEMPTS TO COBBLE TOGETHER NEWFANGLED RESEARCH TO DELINEATE A MEDICAL MODEL FOR THIS 5000-YEAR-OLD PRACTICE FROM INDIA. THIS IS IMPERATIVE, AS A MECHANISTIC MODEL OF THIS ANCIENT-BUT-COMPLEX SYSTEM WOULD ENABLE A MORE COMPREHENSIVE UNDERSTANDING OF ITS MECHANISM AND REVEAL ITS YET-UNDISCOVERED POSITIVE HEALTH EFFECTS. 2021 8 2847 26 YOGA, MEDITATION AND MIND-BODY HEALTH: INCREASED BDNF, CORTISOL AWAKENING RESPONSE, AND ALTERED INFLAMMATORY MARKER EXPRESSION AFTER A 3-MONTH YOGA AND MEDITATION RETREAT. THIRTY-EIGHT INDIVIDUALS (MEAN AGE: 34.8 YEARS OLD) PARTICIPATING IN A 3-MONTH YOGA AND MEDITATION RETREAT WERE ASSESSED BEFORE AND AFTER THE INTERVENTION FOR PSYCHOMETRIC MEASURES, BRAIN DERIVED NEUROTROPHIC FACTOR (BDNF), CIRCADIAN SALIVARY CORTISOL LEVELS, AND PRO- AND ANTI-INFLAMMATORY CYTOKINES. PARTICIPATION IN THE RETREAT WAS FOUND TO BE ASSOCIATED WITH DECREASES IN SELF-REPORTED ANXIETY AND DEPRESSION AS WELL AS INCREASES IN MINDFULNESS. AS HYPOTHESIZED, INCREASES IN THE PLASMA LEVELS OF BDNF AND INCREASES IN THE MAGNITUDE OF THE CORTISOL AWAKENING RESPONSE (CAR) WERE ALSO OBSERVED. THE NORMALIZED CHANGE IN BDNF LEVELS WAS INVERSELY CORRELATED WITH BSI-18 ANXIETY SCORES AT BOTH THE PRE-RETREAT (R = 0.40, P < 0.05) AND POST-RETREAT (R = 0.52, P < 0.005) SUCH THAT THOSE WITH GREATER ANXIETY SCORES TENDED TO EXHIBIT SMALLER PRE- TO POST-RETREAT INCREASES IN PLASMA BDNF LEVELS. IN LINE WITH A HYPOTHESIZED DECREASE IN INFLAMMATORY PROCESSES RESULTING FROM THE YOGA AND MEDITATION PRACTICES, WE FOUND THAT THE PLASMA LEVEL OF THE ANTI-INFLAMMATORY CYTOKINE INTERLEUKIN-10 WAS INCREASED AND THE PRO-INFLAMMATORY CYTOKINE INTERLEUKIN-12 WAS REDUCED AFTER THE RETREAT. CONTRARY TO OUR INITIAL HYPOTHESES, PLASMA LEVELS OF OTHER PRO-INFLAMMATORY CYTOKINES, INCLUDING INTERFERON GAMMA (IFN-GAMMA), TUMOR NECROSIS FACTOR (TNF-ALPHA), INTERLEUKIN-1BETA (IL-1BETA), INTERLEUKIN-6 (IL-6), AND INTERLEUKIN-8 (IL-8) WERE INCREASED AFTER THE RETREAT. GIVEN EVIDENCE FROM PREVIOUS STUDIES OF THE POSITIVE EFFECTS OF MEDITATIVE PRACTICES ON MENTAL FITNESS, AUTONOMIC HOMEOSTASIS AND INFLAMMATORY STATUS, WE HYPOTHESIZE THAT THESE FINDINGS ARE RELATED TO THE MEDITATIVE PRACTICES THROUGHOUT THE RETREAT; HOWEVER, SOME OF THE OBSERVED CHANGES MAY ALSO BE RELATED TO OTHER ASPECTS OF THE RETREAT SUCH AS PHYSICAL EXERCISE-RELATED COMPONENTS OF THE YOGA PRACTICE AND DIET. WE HYPOTHESIZE THAT THE PATTERNS OF CHANGE OBSERVED HERE REFLECT MIND-BODY INTEGRATION AND WELL-BEING. THE INCREASED BDNF LEVELS OBSERVED IS A POTENTIAL MEDIATOR BETWEEN MEDITATIVE PRACTICES AND BRAIN HEALTH, THE INCREASED CAR IS LIKELY A REFLECTION OF INCREASED DYNAMIC PHYSIOLOGICAL AROUSAL, AND THE RELATIONSHIP OF THE DUAL ENHANCEMENT OF PRO- AND ANTI-INFLAMMATORY CYTOKINE CHANGES TO HEALTHY IMMUNOLOGIC FUNCTIONING IS DISCUSSED. 2017 9 1967 22 SERUM CORTISOL AND BDNF IN PATIENTS WITH MAJOR DEPRESSION-EFFECT OF YOGA. DEPRESSION IS ASSOCIATED WITH LOW SERUM BRAIN DERIVED NEUROTROPHIC FACTOR (BDNF) AND ELEVATED LEVELS OF SERUM CORTISOL. YOGA PRACTICES HAVE BEEN ASSOCIATED WITH ANTIDEPRESSANT EFFECTS, INCREASE IN SERUM BDNF, AND REDUCTION IN SERUM CORTISOL. THIS STUDY EXAMINED THE ASSOCIATION BETWEEN SERUM BDNF AND CORTISOL LEVELS IN DRUG-NAIVE PATIENTS WITH DEPRESSION TREATED WITH ANTIDEPRESSANTS, YOGA THERAPY, AND BOTH. FIFTY-FOUR DRUG-NAIVE CONSENTING ADULT OUTPATIENTS WITH MAJOR DEPRESSION (32 MALES) RECEIVED ANTIDEPRESSANTS ONLY (N = 16), YOGA THERAPY ONLY (N = 19), OR YOGA WITH ANTIDEPRESSANTS (N = 19). SERUM BDNF ANDCORTISOL LEVELS WERE OBTAINED BEFORE AND AFTER 3 MONTHS USING A SANDWICH ELISA METHOD. ONE-WAY ANOVA, CHI-SQUARE TEST, AND PEARSON'S CORRELATION TESTS WERE USED FOR ANALYSIS. THE GROUPS WERE COMPARABLE AT BASELINE ON MOST PARAMETERS. SIGNIFICANT IMPROVEMENT IN DEPRESSION SCORES AND SERUM BDNF LEVELS, AND REDUCTION IN SERUM CORTISOL IN THE YOGA GROUPS, HAVE BEEN DESCRIBED IN PREVIOUS REPORTS. A SIGNIFICANT NEGATIVE CORRELATION WAS OBSERVED BETWEEN CHANGE IN BDNF (PRE-POST) AND CORTISOL (PRE-POST) LEVELS IN THE YOGA-ONLY GROUP (R = -0.59, P = 0.008). IN CONCLUSION, YOGA MAY FACILITATE NEUROPLASTICITY THROUGH STRESS REDUCTION IN DEPRESSED PATIENTS. FURTHER STUDIES ARE NEEDED TO CONFIRM THE FINDINGS AND DELINEATE THE PATHWAYS FOR THESE EFFECTS. 2016 10 1761 24 POSITIVE THERAPEUTIC AND NEUROTROPIC EFFECTS OF YOGA IN DEPRESSION: A COMPARATIVE STUDY. CONTEXT: THERAPEUTIC EFFECT OF YOGA IN DEPRESSION IS RECOGNIZED. NEUROPLASTIC EFFECTS OF ANTIDEPRESSANT THERAPIES ARE INFERRED BY ELEVATIONS IN BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF). ROLE OF YOGA IN BOTH THESE EFFECTS HAS NOT BEEN STUDIED. MATERIALS AND METHODS: NON-SUICIDAL, CONSECUTIVE OUT-PATIENTS OF DEPRESSION WERE OFFERED YOGA EITHER ALONE OR WITH ANTIDEPRESSANTS. THE DEPRESSION SEVERITY WAS RATED ON HAMILTON DEPRESSION RATING SCALE (HDRS) BEFORE AND AT 3 MONTHS. SERUM BDNF LEVELS WERE MEASURED AT THE SAME TIME POINTS. REPEATED-MEASURES ANALYSIS OF VARIANCE WAS PERFORMED TO LOOK AT CHANGE ACROSS GROUPS WITH RESPECT TO HDRS SCORES AND BDNF LEVELS OVER 3 MONTHS OF FOLLOW-UP. RELATIONSHIP BETWEEN CHANGE IN SERUM BDNF LEVELS AND CHANGE IN HDRS SCORES WAS ASSESSED USING THE PEARSON'S CORRELATION COEFFICIENT. RESULTS: BOTH YOGA GROUPS WERE BETTER THAN DRUGS-ONLY GROUP WITH RESPECT TO REDUCTION IN HDRS SCORES. SERUM BDNF ROSE IN THE TOTAL SAMPLE IN THE 3-MONTH PERIOD. THIS WAS NOT, HOWEVER, DIFFERENT ACROSS TREATMENT GROUPS. THERE WAS A SIGNIFICANT POSITIVE CORRELATION BETWEEN FALL IN HDRS AND RISE IN SERUM BDNF LEVELS IN YOGA-ONLY GROUP (R=0.702; P=0.001), BUT NOT IN THOSE RECEIVING YOGA AND ANTIDEPRESSANTS OR ANTIDEPRESSANTS-ALONE. CONCLUSIONS: NEUROPLASTIC MECHANISMS MAY BE RELATED TO THE THERAPEUTIC MECHANISMS OF YOGA IN DEPRESSION. 2013 11 2106 21 THE EFFECT OF YOGA ON NEUROTICISM IN AN INDIAN POPULATION VARIES WITH SOCIO-DEMOGRAPHIC FACTORS. NEUROTICISM, OR NEGATIVE AFFECTIVITY, CAN INFLUENCE A PERSON'S APPROACH TO LIFE. THIS STUDY EXAMINED LEVELS OF NEUROTICISM IN 249 PATIENTS WITH ILLNESSES KNOWN TO BE RELATED TO THE MENTAL STATE. ALL OF THEM WERE GIVEN A SIX-DAY INTENSIVE YOGA PROGRAM. PATIENTS SHOWED A DECREASE IN NEUROTICISM MEASURED BY THE PGI HEALTH QUESTIONNAIRE. THE REDUCTION WAS MAXIMUM FOR (A) THOSE WITH AGES BETWEEN 36 AND 51 YEARS, (B) FEMALES, (C) PATIENTS WITH AT LEAST 17 YEARS OF EDUCATION, AND (D) THOSE WHO WERE SELF-EMPLOYED. THE RESULTS SHOW THE IMPORTANCE OF SOCIO-DEMOGRAPHIC FACTORS IN NEUROTICISM LEVELS AND IN PROGRAMS INTENDED TO REDUCE NEUROTICISM. HENCE, YOGA IS A USEFUL INTERVENTION TO REDUCE TRAITS OF NEUROTICISM, WITH VARIATIONS IN THE DEGREE OF CHANGE BASED ON SOCIAL FACTORS. 2012 12 1089 27 EFFECTS OF YOGA ON THE AUTONOMIC NERVOUS SYSTEM, GAMMA-AMINOBUTYRIC-ACID, AND ALLOSTASIS IN EPILEPSY, DEPRESSION, AND POST-TRAUMATIC STRESS DISORDER. A THEORY IS PROPOSED TO EXPLAIN THE BENEFITS OF YOGA PRACTICES IN DIVERSE, FREQUENTLY COMORBID MEDICAL CONDITIONS BASED ON THE CONCEPT THAT YOGA PRACTICES REDUCE ALLOSTATIC LOAD IN STRESS RESPONSE SYSTEMS SUCH THAT OPTIMAL HOMEOSTASIS IS RESTORED. IT IS HYPOTHESIZED THAT STRESS INDUCES (1) IMBALANCE OF THE AUTONOMIC NERVOUS SYSTEM (ANS) WITH DECREASED PARASYMPATHETIC NERVOUS SYSTEM (PNS) AND INCREASED SYMPATHETIC NERVOUS SYSTEM (SNS) ACTIVITY, (2) UNDERACTIVITY OF THE GAMMA AMINO-BUTYRIC ACID (GABA) SYSTEM, THE PRIMARY INHIBITORY NEUROTRANSMITTER SYSTEM, AND (3) INCREASED ALLOSTATIC LOAD. IT IS FURTHER HYPOTHESIZED THAT YOGA-BASED PRACTICES (4) CORRECT UNDERACTIVITY OF THE PNS AND GABA SYSTEMS IN PART THROUGH STIMULATION OF THE VAGUS NERVES, THE MAIN PERIPHERAL PATHWAY OF THE PNS, AND (5) REDUCE ALLOSTATIC LOAD. DEPRESSION, EPILEPSY, POST TRAUMATIC STRESS DISORDER (PTSD), AND CHRONIC PAIN EXEMPLIFY MEDICAL CONDITIONS THAT ARE EXACERBATED BY STRESS, HAVE LOW HEART RATE VARIABILITY (HRV) AND LOW GABAERGIC ACTIVITY, RESPOND TO PHARMACOLOGIC AGENTS THAT INCREASE ACTIVITY OF THE GABA SYSTEM, AND SHOW SYMPTOM IMPROVEMENT IN RESPONSE TO YOGA-BASED INTERVENTIONS. THE OBSERVATION THAT TREATMENT RESISTANT CASES OF EPILEPSY AND DEPRESSION RESPOND TO VAGAL NERVE STIMULATION CORROBORATES THE NEED TO CORRECT PNS UNDERACTIVITY AS PART OF A SUCCESSFUL TREATMENT PLAN IN SOME CASES. ACCORDING TO THE PROPOSED THEORY, THE DECREASED PNS AND GABAERGIC ACTIVITY THAT UNDERLIES STRESS-RELATED DISORDERS CAN BE CORRECTED BY YOGA PRACTICES RESULTING IN AMELIORATION OF DISEASE SYMPTOMS. THIS HAS FAR-REACHING IMPLICATIONS FOR THE INTEGRATION OF YOGA-BASED PRACTICES IN THE TREATMENT OF A BROAD ARRAY OF DISORDERS EXACERBATED BY STRESS. 2012 13 1347 41 HYPOXIA IN CNS PATHOLOGIES: EMERGING ROLE OF MIRNA-BASED NEUROTHERAPEUTICS AND YOGA BASED ALTERNATIVE THERAPIES. CELLULAR RESPIRATION IS A VITAL PROCESS FOR THE EXISTENCE OF LIFE. ANY CONDITION THAT RESULTS IN DEPRIVATION OF OXYGEN (ALSO TERMED AS HYPOXIA) MAY EVENTUALLY LEAD TO DELETERIOUS EFFECTS ON THE FUNCTIONING OF TISSUES. BRAIN BEING THE HIGHEST CONSUMER OF OXYGEN IS PRONE TO INCREASED RISK OF HYPOXIA-INDUCED NEUROLOGICAL INSULTS. THIS IN TURN HAS BEEN ASSOCIATED WITH MANY DISEASES OF CENTRAL NERVOUS SYSTEM (CNS) SUCH AS STROKE, ALZHEIMER'S, ENCEPHALOPATHY ETC. ALTHOUGH SEVERAL STUDIES HAVE INVESTIGATED THE PATHOPHYSIOLOGICAL MECHANISMS UNDERLYING ISCHEMIC/HYPOXIC CNS DISEASES, THE KNOWLEDGE ABOUT PROTECTIVE THERAPEUTIC STRATEGIES TO AMELIORATE THE AFFECTED NEURONAL CELLS IS MEAGER. THIS HAS AUGMENTED THE NEED TO IMPROVE OUR UNDERSTANDING OF THE HYPOXIC AND ISCHEMIC EVENTS OCCURRING IN THE BRAIN AND IDENTIFY NOVEL AND ALTERNATE TREATMENT MODALITIES FOR SUCH INSULTS. MICRORNA (MIRNAS), SMALL NON-CODING RNA MOLECULES, HAVE RECENTLY EMERGED AS POTENTIAL NEUROPROTECTIVE AGENTS AS WELL AS TARGETS, UNDER HYPOXIC CONDITIONS. THESE 18-22 NUCLEOTIDE LONG RNA MOLECULES ARE PROFUSELY PRESENT IN BRAIN AND OTHER ORGANS AND FUNCTION AS GENE REGULATORS BY CLEAVING AND SILENCING THE GENE EXPRESSION. IN BRAIN, THESE ARE KNOWN TO BE INVOLVED IN NEURONAL DIFFERENTIATION AND PLASTICITY. THEREFORE, TARGETING MIRNA EXPRESSION REPRESENTS A NOVEL THERAPEUTIC APPROACH TO INTERCEDE AGAINST HYPOXIC AND ISCHEMIC BRAIN INJURY. IN THE FIRST PART OF THIS REVIEW, WE WILL DISCUSS THE NEUROPHYSIOLOGICAL CHANGES CAUSED AS A RESULT OF HYPOXIA, FOLLOWED BY THE CONTRIBUTION OF HYPOXIA IN THE NEURODEGENERATIVE DISEASES. SECONDLY, WE WILL PROVIDE RECENT UPDATES AND INSIGHTS INTO THE ROLES OF MIRNA IN THE REGULATION OF GENES IN OXYGEN AND GLUCOSE DEPRIVED BRAIN IN ASSOCIATION WITH CIRCADIAN RHYTHMS AND HOW THESE CAN BE TARGETED AS NEUROPROTECTIVE AGENTS FOR CNS INJURIES. FINALLY, WE WILL EMPHASIZE ON ALTERNATE BREATHING OR YOGIC INTERVENTIONS TO OVERCOME THE HYPOXIA ASSOCIATED ANOMALIES THAT COULD ULTIMATELY LEAD TO IMPROVEMENT IN CEREBRAL PERFUSION. 2017 14 2272 33 THE ROLE OF YOGA IN INFLAMMATORY MARKERS. YOGA IS AN ANCIENT SYSTEM FOR INTEGRATING THE MIND, BODY, AND SPIRIT. IN THE HATHA YOGA ASHTANGA TRADITION (THE EIGHT LIMB PATANJALI YOGA), THREE OF THE LIMBS ARE MEDITATION, BREATHWORK (PRANAYAMA) AND PHYSICAL POSTURES (ASANA), WHICH ARE WIDELY PRACTISED IN YOGA CLASSES. THE BENEFITS OF YOGA FOR MENTAL AND PHYSICAL HEALTH ARE ROOTED IN THE PRACTICE'S ORIGINS: IN YOGA, STRESS IS SAID TO BE THE ROOT OF ALL DISEASES. THE ESTABLISHED FIELDS OF PSYCHONEUROIMMUNOLOGY AND IMMUNOPSYCHIATRY STUDY THE INTERPLAY BETWEEN THE IMMUNE SYSTEM AND MOOD OR MENTAL STATES. THIS MINI-REVIEW HAS SHIFTED THE EMPHASIS FROM RESEARCH THAT FOCUSES ON YOGA'S BENEFITS FOR STRESS, THE MOST COMMONLY STUDIED OUTCOME OF YOGA RESEARCH, TO A SUMMARY OF THE RESEARCH ON THE EFFECTS OF YOGA PRACTICES ON THE IMMUNE SYSTEM. THE CURRENT LITERATURE BEARS STRONG EVIDENCE FOR THE BENEFITS OF YOGA ON THE LEVELS OF CIRCULATING CORTISOL AND CLASSICAL INFLAMMATORY MARKERS, SUCH AS C-REACTIVE PROTEIN (CRP) AND CYTOKINES SUCH AS INTERLEUKIN-1 BETA (IL-1BETA), INTERLEUKIN 6 (IL-6), TUMOUR NECROSIS FACTOR-ALPHA (TNF-ALPHA) AND INTERFERON-GAMMA (INF-GAMMA). THE EVIDENCE FOR OTHER LESS STUDIED MARKERS, TELOMERASE ACTIVITY, BETA-ENDORPHINS, IMMUNOGLOBULIN A (IGA) AND BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) IS ALSO GROWING. THIS MINI-REVIEW CENTRES AROUND THE INTERPLAY BETWEEN YOGA AND THESE MARKERS IN STRESS MANAGEMENT AND DEPRESSION, VASCULAR AND IMMUNE FUNCTION IN THE OLDER POPULATION, CARDIOVASCULAR AND METABOLIC DISEASES, AUTO-IMMUNE DISEASES, BREAST CANCER AND PREGNANCY. OVERALL, THE LITERATURE EXAMINED REVEALS THE NOVELTY OF THIS FIELD OF RESEARCH AND SHEDS LIGHT ON METHODOLOGICAL CHALLENGES; HOWEVER, IT UNCOVERS THE POTENTIAL FOR YOGA TO BE USED AS ADJUVANT THERAPY IN CONDITIONS WITH AN INFLAMMATORY COMPONENT. 2022 15 1012 26 EFFECTS OF ONE MONTH OF COMMON YOGA PROTOCOL PRACTICE APPEAR TO BE MEDIATED BY THE ANGIOGENIC AND NEUROGENIC PATHWAY: A PILOT STUDY. OBJECTIVE: TO EXAMINE THE MOLECULAR EFFECTS OF MINDFUL ACTIVITIES SUCH AS YOGA AND MEDITATION DESIGN: THIS WAS AN OPEN LABEL SINGLE ARM EXPLORATORY YOGA INTERVENTION STUDY. STUDY PARTICIPANTS: 64 HEALTHY INDIVIDUALS WITHIN THE AGE OF 18-60 YEARS WERE RECRUITED FOR THIS ONE MONTH YOGA INTERVENTION STUDY. INTERVENTION: COMMON YOGA PROTOCOL (CYP) IS A STANDARDIZED YOGA PROTOCOL RELEASED BY MINISTRY OF AYUSH, INDIA FOR INTERNATIONAL YOGA DAY. IT INCLUDES ALL ASPECTS OF YOGA I.E. ASANAS, PRANAYAMA AND MEDITATION. IT IS DESIGNED FOR ADOPTION BY ALL AGE GROUPS FOR THE HEALTH OF COMMUNITY. OUTCOME MEASURES: THE PARTICIPANTS WERE ASSESSED FOR BIOCHEMICAL PARAMETERS INCLUDING FASTING SUGAR AND LIPID PROFILE. THE MOLECULAR MARKERS OF NEUROGENESIS (I.E. BRAIN DERIVED NEUROTROPIC FACTOR, BDNF) AND ANGIOGENESIS (I.E. VASCULAR ENDOTHELIAL GROWTH FACTOR, VEGF AND ANGIOGENIN) ALONG WITH AMYLOID BETA (MARKER RELATED TO NEURO-DEGENERATIVE DISEASES) WERE ASSESSED. ALL THE ASSESSMENTS WERE MADE AT BASELINE AND AFTER ONE MONTH OF THE INTERVENTION. RESULTS: AFTER ONE MONTH OF CYP PRACTICE HIGH DENSITY LIPOPROTEIN (HDL) LEVELS INCREASED SIGNIFICANTLY (P<0.001), ALTHOUGH OTHER BIOCHEMICAL PARAMETERS I.E. FASTING SUGAR AND OTHER LIPID ASSESSMENTS WERE FOUND TO BE UNALTERED. ANGIOGENESIS MARKER, ANGIOGENIN WAS INCREASED SIGNIFICANTLY (P<0.002), OTHER ANGIOGENESIS MARKER VEGF DID NOT SHOW ANY CHANGE ALONG WITH BDNF, MARKER OF NEUROGENESIS. AMYLOID BETA LEVELS WERE ALSO UNALTERED. EVEN THOUGH INDIVIDUAL LEVELS OF VEGF AND AMYLOID BETA DID NOT SHOW ANY CHANGE, PROPORTION OF VEGF TO AMYLOID BETA SHOWED A SIGNIFICANT INCREASE (P<0.001) AFTER ONE MONTH OF CYP INTERVENTION INDICATING THAT THE CHANGE IN VEGF LEVELS WAS SIGNIFICANTLY HIGHER THAN THE CHANGE IN AMYLOID BETA LEVELS. CONCLUSION: CYP PRACTICE MAY INFLUENCE CELL SURVIVAL PATHWAYS MEDIATED BY ANGIOGENIC AND NEUROGENIC CROSS TALK. HENCE, CYP CAN BE CONSIDERED AS A PREVENTIVE MEASURE FOR DISEASES ASSOCIATED WITH IMPAIRED ANGIOGENIC AND NEUROGENIC MECHANISM. THIS IS THE FIRST STUDY TO EXAMINE THE EFFECTS OF CYP AT THE MOLECULAR LEVEL. 2021 16 1149 33 ENHANCEMENT OF CANCER STEM CELL SUSCEPTIBILITY TO CONVENTIONAL TREATMENTS THROUGH COMPLEMENTARY YOGA THERAPY: POSSIBLE CELLULAR AND MOLECULAR MECHANISMS. CANCER STEM CELLS (CSCS) ARE STEM-LIKE TUMOR POPULATIONS THAT ARE REPORTED TO CONTRIBUTE TOWARDS TUMOR GROWTH, MAINTENANCE AND RECURRENCE AFTER THERAPY. HYPOXIA INCREASES CSC FRACTION AND PROMOTES ACQUISITION OF A STEM-CELL-LIKE STATE. CANCER STEM CELLS ARE CRITICALLY DEPENDANT ON THE HYPOXIA-INDUCIBLE FACTOR-1 (HIF-1) FOR SURVIVAL, SELF-RENEWAL, TUMOR GROWTH AND MAINTENANCE OF THEIR UNDIFFERENTIATED PHENOTYPE. RECENT RESEARCHES SHOW THAT STAGE OF DIFFERENTIATION OF THE TUMOR CELLS IS PREDICTIVE OF THEIR SUSCEPTIBILITY TO NATURAL KILLER CELL (NK) CELL MEDIATED CYTOTOXICITY AND CANCER STEM CELLS ARE SIGNIFICANT TARGETS OF NK CELL CYTOTOXICITY. STUDIES ALSO SHOW THAT REVERSION OF TUMOR CELLS TO A LESS-DIFFERENTIATED PHENOTYPE CAN BE ACHIEVED BY BLOCKING NFKAPPAB. YOGA THERAPY (YOGIC LIFESTYLE MODIFICATIONS ENCOMPASSING PHYSICAL POSTURES, BREATHING PRACTICES, RELAXATION TECHNIQUES AND MEDITATIONS) IS KNOWN TO MODULATE NEURAL, ENDOCRINE AND IMMUNE FUNCTIONS AT THE CELLULAR LEVEL THROUGH INFLUENCING CELL CYCLE CONTROL, AGING, OXIDATIVE STRESS, APOPTOSIS AND SEVERAL PATHWAYS OF STRESS SIGNALING MOLECULES. YOGA THERAPY HAS ALSO BEEN SHOWN TO ENHANCE NATURAL KILLER CELL ACTIVITY AND MODULATE STRESS AND DNA DAMAGE IN BREAST CANCER PATIENTS RECEIVING RADIOTHERAPY. RECENT STUDY FOUND THAT BRIEF DAILY YOGIC MEDITATION MAY REVERSE THE PATTERN OF INCREASED NFKAPPAB-RELATED TRANSCRIPTION OF PRO-INFLAMMATORY CYTOKINES IN LEUKOCYTES. THUS, YOGA THERAPY HAS THE POTENTIAL TO REDUCE CANCER STEM CELL SURVIVAL, SELF -RENEWAL AND TUMOR GROWTH BY MODIFYING THE TUMOR MICRO-ENVIRONMENT THROUGH VARIOUS MECHANISMS SUCH AS; 1) REDUCING HIF-1 ACTIVITY BY ENHANCED OXYGENATION, 2) PROMOTING NK CELL ACTIVITY DIRECTLY (OR INDIRECTLY THROUGH DOWN REGULATING NFKAPPAB EXPRESSION), THEREBY ENHANCING NK CELL MEDIATED CSC LYSIS, AND 3) BY MINIMIZING THE ABERRANT EXPRESSIONS OR ACTIVITIES OF VARIOUS HORMONES, CYTOKINES, CHEMOKINES AND TUMOR SIGNALING PATHWAYS. YOGA THERAPY MAY HAVE A SYNERGISTIC EFFECT WITH CONVENTIONAL MODALITIES OF TREATMENT IN PREVENTING CANCER PROGRESSION AND RECURRENCES. 2012 17 439 18 CARDIOVASCULAR, CELLULAR, AND NEURAL ADAPTATIONS TO HOT YOGA VERSUS NORMAL-TEMPERATURE YOGA. CONTEXT: CHRONIC HEAT EXPOSURE PROMOTES CARDIOVASCULAR AND CELLULAR ADAPTATIONS, IMPROVING AN ORGANISM'S ABILITY TO TOLERATE SUBSEQUENT STRESSORS. HEAT EXPOSURE MAY ALSO PROMOTE NEURAL ADAPTATIONS AND ALTER THE NEURAL-HORMONAL STRESS RESPONSE. HOT-TEMPERATURE YOGA (HY) COMBINES MIND-BODY EXERCISE WITH HEAT EXPOSURE. THE ADDED HEAT COMPONENT IN HY MAY INDUCE CARDIOVASCULAR AND CELLULAR CHANGES, ALONG WITH NEURAL BENEFITS AND MODULATION OF STRESS HORMONES. AIMS: THE PURPOSE OF THE PRESENT STUDY IS TO COMPARE THE CARDIOVASCULAR, CELLULAR HEAT SHOCK PROTEIN 70 (HSP70), NEURAL, AND HORMONAL ADAPTATIONS OF HY VERSUS NORMAL-TEMPERATURE YOGA (NY). SETTINGS AND DESIGN: TWENTY-TWO SUBJECTS (MALES = 11 AND FEMALES = 11, 26 +/- 6 YEARS) COMPLETED 4 WEEKS OF NY (N = 11) OR HY (N = 11, 41 DEGREES C, 40% HUMIDITY). YOGA SESSIONS WERE PERFORMED 3 TIMES/WEEK FOLLOWING A MODIFIED BIKRAM PROTOCOL. SUBJECTS AND METHODS: PRE- AND POSTTESTING INCLUDED (1) HEMODYNAMIC MEASURES DURING A HEAT TOLERANCE TEST AND MAXIMAL AEROBIC FITNESS TEST; (2) NEURAL AND HORMONAL ADAPTATIONS USING SERUM BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) AND ADRENOCORTICOTROPIC HORMONE (ACTH), ALONG WITH A MENTAL STRESS QUESTIONNAIRE; AND (3) CELLULAR ADAPTATIONS (HSP70) IN PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMCS). STATISTICAL ANALYSIS: WITHIN- AND BETWEEN-GROUP STUDENT'S T-TEST ANALYSES WERE CONDUCTED TO COMPARE PRE- AND POST-VO2 MAX, PERCEIVED STRESS, BDNF, HSP70, AND ACTH IN HY AND NY GROUPS. RESULTS: MAXIMAL AEROBIC FITNESS INCREASED IN THE HY GROUP ONLY. NO EVIDENCE OF HEAT ACCLIMATION OR CHANGE IN MENTAL STRESS WAS OBSERVED. SERUM BDNF SIGNIFICANTLY INCREASED IN YOGA GROUPS COMBINED. ANALYSIS OF HSP70 SUGGESTED HIGHER EXPRESSION OF HSP70 IN THE HY GROUP ONLY. CONCLUSIONS: TWELVE SESSIONS OF HY PROMOTED CARDIOVASCULAR FITNESS AND CELLULAR THERMOTOLERANCE ADAPTATIONS. SERUM BDNF INCREASED IN RESPONSE TO YOGA (NY + HY) AND APPEARED TO NOT BE TEMPERATURE DEPENDENT. 2021 18 2776 20 YOGA SCHOOL OF THOUGHT AND PSYCHIATRY: THERAPEUTIC POTENTIAL. YOGA IS A TRADITIONAL LIFE-STYLE PRACTICE USED FOR SPIRITUAL REASONS. HOWEVER, THE PHYSICAL COMPONENTS LIKE THE ASANAS AND PRANAYAAMAS HAVE DEMONSTRATED PHYSIOLOGICAL AND THERAPEUTIC EFFECTS. THERE IS EVIDENCE FOR YOGA AS BEING A POTENT ANTIDEPRESSANT THAT MATCHES WITH DRUGS. IN DEPRESSIVE DISORDER, YOGA 'CORRECTS' AN UNDERLYING COGNITIVE PHYSIOLOGY. IN SCHIZOPHRENIA PATIENTS, YOGA HAS BENEFITS AS AN ADD-ON INTERVENTION IN PHARMACOLOGICALLY STABILIZED SUBJECTS. THE EFFECTS ARE PARTICULARLY NOTABLE ON NEGATIVE SYMPTOMS. YOGA ALSO HELPS TO CORRECT SOCIAL COGNITION. YOGA CAN BE INTRODUCED EARLY IN THE TREATMENT OF PSYCHOSIS WITH SOME BENEFITS. ELEVATION OF OXYTOCIN MAY BE A MECHANISM OF YOGA EFFECTS IN SCHIZOPHRENIA. CERTAIN COMPONENTS OF YOGA HAVE DEMONSTRATED NEUROBIOLOGICAL EFFECTS SIMILAR TO THOSE OF VAGAL STIMULATION, INDICATING THIS (INDIRECT OR AUTOGENOUS VAGAL STIMULATION) AS A POSSIBLE MECHANISM OF ITS ACTION. IT IS TIME, PSYCHIATRISTS EXPLOITED THE BENEFITS IF YOGA FOR A COMPREHENSIVE CARE IN THEIR PATIENTS. 2013 19 422 26 BRIDGING THE SCHISM OF SCHIZOPHRENIA THROUGH YOGA-REVIEW OF PUTATIVE MECHANISMS. SCHIZOPHRENIA PATIENTS EXPERIENCE A 'DISCONNECT' AT MULTIPLE LEVELS-NEURONAL NETWORKS, MENTAL PROCESSES, AND INTERPERSONAL RELATIONSHIPS. THE RESULTANT POOR QUALITY-OF-LIFE AND FUNCTIONAL DISABILITY ARE RELATED TO THE PERSISTENT COGNITIVE DEFICITS AND NEGATIVE SYMPTOMS, WHICH ARE RATHER RESISTANT TO CONVENTIONAL ANTIPSYCHOTIC MEDICATIONS. YOGA HAS EMERGED AS AN IMPORTANT THERAPEUTIC INTERVENTION TO IMPROVE QUALITY-OF-LIFE IN SCHIZOPHRENIA. RECENT PRELIMINARY EVIDENCE SUGGESTS THAT EFFECTS OF YOGA ON COGNITIVE AND NEGATIVE SYMPTOMS MAY DRIVE THIS BENEFIT. THIS STUDY ATTEMPTS TO INTEGRATE EVIDENCE FROM NEUROSCIENCE-BASED RESEARCH, WHICH FOCUSES ON THE NEUROPLASTICITY-HARNESSING EFFECTS OF YOGA TO BRIDGE THE SCHIZOPHRENIA CONNECTOPATHY. IN AN OVERARCHING MODEL TO STUDY PUTATIVE NEUROBIOLOGICAL MECHANISMS THAT DRIVE THERAPEUTIC EFFECTS OF YOGA, IT IS PROPOSED THAT (A) VARIOUS STYLES OF MEDITATION MAY HELP IN STRENGTHENING THE LATERAL AND MEDIAL PREFRONTAL BRAIN NETWORKS, THUS IMPROVING NEUROCOGNITION AND MENTALIZING ABILITIES, AND (B) LEARNING AND PERFORMING CO-ORDINATED PHYSICAL POSTURES WITH A TEACHER FACILITATES IMITATION AND THE PROCESS OF BEING IMITATED, WHICH CAN IMPROVE SOCIAL COGNITION AND EMPATHY THROUGH REINFORCEMENT OF THE PREMOTOR AND PARIETAL MIRROR NEURON SYSTEM. OXYTOCIN MAY PLAY A ROLE IN MEDIATING THESE PROCESSES, LEADING TO BETTER SOCIAL CONNECTEDNESS AND SOCIAL OUTCOMES. CLINICAL AND HEURISTIC IMPLICATIONS OF THIS MODEL ARE FURTHER DISCUSSED. 2016 20 225 25 A SYSTEMATIC REVIEW OF MECHANISMS OF CHANGE IN BODY-ORIENTED YOGA IN MAJOR DEPRESSIVE DISORDERS. INTRODUCTION: DESPITE EMPIRICAL EVIDENCE FOR THE EFFICACY OF BODY-ORIENTED YOGA AS ADD-ON TREATMENT FOR MAJOR DEPRESSIVE DISORDER (MDD), THE SPECIFIC MECHANISMS BY WHICH YOGA LEADS TO THERAPEUTIC CHANGES REMAIN UNCLEAR. BY MEANS OF A SYSTEMATIC REVIEW, WE EVALUATE HOW THE FIELD IS PROGRESSING IN ITS EMPIRICAL INVESTIGATION OF MECHANISMS OF CHANGE IN YOGA FOR MDD. METHODS: TO IDENTIFY RELEVANT STUDIES, A SYSTEMATIC SEARCH WAS CONDUCTED. RESULTS: THE SEARCH PRODUCED 441 ARTICLES, OF WHICH 5 WERE INCLUDED, THAT EMPIRICALLY EXAMINED 2 PSYCHOLOGICAL MECHANISMS (MINDFULNESS, RUMINATION) AND 3 BIOLOGICAL MECHANISMS (VAGAL CONTROL, HEART RATE VARIABILITY [HRV], BRAIN-DERIVED NEUROTROPHIC FACTOR [BDNF], CORTISOL). 2 STUDIES FOUND THAT DECREASED RUMINATION AND 1 STUDY THAT INCREASED MINDFULNESS WAS ASSOCIATED WITH THE EFFECT OF YOGA ON TREATMENT OUTCOME. IN ADDITION, PRELIMINARY STUDIES SUGGEST THAT ALTERATIONS IN CORTISOL, BDNF, AND HRV MAY PLAY A ROLE IN HOW YOGA EXERTS ITS CLINICAL EFFECT. DISCUSSION: THE RESULTS SUGGEST THAT BODY-ORIENTED YOGA COULD WORK THROUGH SOME OF THE THEORETICALLY PREDICTED MECHANISMS. HOWEVER, THERE IS A NEED FOR MORE RIGOROUS DESIGNS THAT CAN ASSESS GREATER LEVELS OF CAUSAL SPECIFICITY. 2018